| P2093 | author name string | John R. Stroehlein | |
| P2860 | cites work | Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii | Q68841505 |
| | Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study | Q69182379 |
| | Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients | Q69370183 |
| | Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG | Q69911178 |
| | Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism | Q69943295 |
| | Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum | Q70634956 |
| | Bacitracin treatment of antibiotic-associated colitis and diarrhea caused by Clostridium difficile toxin | Q71184055 |
| | Colitis associated with metronidazole therapy | Q71243568 |
| | Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces | Q71408119 |
| | Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants | Q73592019 |
| | Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection | Q24676013 |
| | Clostridium difficile and the aetiology of pseudomembranous colitis | Q34058811 |
| | Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis | Q34247700 |
| | Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing Clostridia | Q34708067 |
| | Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin | Q34880915 |
| | Intravenous immunoglobulin therapy for severe Clostridium difficile colitis | Q35841034 |
| | The influence of the normal flora on Clostridium difficile colonisation of the gut. | Q37919095 |
| | Oral vancomycin for antibiotic-associated pseudomembranous colitis | Q39498171 |
| | Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial | Q40654528 |
| | Clostridium difficile colitis | Q40679117 |
| | Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease | Q40840258 |
| | Immune response to Clostridium difficile infection | Q41244642 |
| | Nosocomial acquisition of Clostridium difficile infection | Q41877583 |
| | Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii | Q44084557 |
| | Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens | Q44770189 |
| | Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. | Q45980203 |
| P433 | issue | 3 | |
| P921 | main subject | Clostridium difficile | Q310543 |
| P304 | page(s) | 235-239 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | Current treatment options in gastroenterology | Q27714745 |
| P1476 | title | Treatment of Clostridium difficile Infection | |
| P478 | volume | 7 | |